Loading...
Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL(3)B
BACKGROUND: The high rate of mortality due to malaria and the worldwide distribution of parasite resistance to the commonly used antimalarial drugs chloroquine and pyrimethamine emphasize the urgent need for the development of new antimalarial drugs. An alternative approach to the long and uncertain...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2213633/ https://ncbi.nlm.nih.gov/pubmed/17956613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-7-13 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|